| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A999269 | Anti-TYRO3 Reference Antibody (ELB031), Anti-TYRO3 Reference Antibody (ELB031), |
|||
| A999270 | Anti-VCAM1 / CD106 Reference Antibody (Hanwha patent anti-VCAM-1), Anti-VCAM1 / CD106 Reference Antibody (Hanwha patent anti-VCAM-1), |
|||
| A999271 | Anti-VEGF Reference Antibody (BioMab patent anti-VEGF), Anti-VEGF Reference Antibody (BioMab patent anti-VEGF), |
|||
| A999272 | Anti-VEGF Reference Antibody (Domantis patent anti-VEGF), Anti-VEGF Reference Antibody (Domantis patent anti-VEGF), |
|||
| A999273 | Anti-VEGFA Reference Antibody (bevacizumab), Anti-VEGFA Reference Antibody (bevacizumab), |
|||
| A999274 | Anti-VEGFA Reference Antibody (ranibizumab), Anti-VEGFA Reference Antibody (ranibizumab), |
|||
| A999275 | Anti-VEGFA Reference Antibody (varisacumab), Anti-VEGFA Reference Antibody (varisacumab), |
|||
| A999276 | Anti-VEGFB Reference Antibody (CSL346), Anti-VEGFB Reference Antibody (CSL346), |
|||
| A999277 | Anti-VEGFC Reference Antibody (VGX100), Anti-VEGFC Reference Antibody (VGX100), |
|||
| A999278 | Anti-VEGFR1 / FLT1 Reference Antibody (Abbott patent anti-Flt1), Anti-VEGFR1 / FLT1 Reference Antibody (Abbott patent anti-Flt1), |
|||
| A999279 | Anti-VEGFR1 / FLT1 Reference Antibody (icrucumab), Anti-VEGFR1 / FLT1 Reference Antibody (icrucumab), |
|||
| A999280 | Anti-VEGFR2 / KDR / CD309 Reference Antibody (alacizumAb), Anti-VEGFR2 / KDR / CD309 Reference Antibody (alacizumAb), |
|||
| A999281 | Anti-VEGFR2 / KDR / CD309 Reference Antibody (AT001), Anti-VEGFR2 / KDR / CD309 Reference Antibody (AT001), |
|||
| A999282 | Anti-VEGFR2 / KDR / CD309 Reference Antibody (Imclone 6.64), Anti-VEGFR2 / KDR / CD309 Reference Antibody (Imclone 6.64), |
|||
| A999283 | Anti-VEGFR2 / KDR / CD309 Reference Antibody (olinvacimab), Anti-VEGFR2 / KDR / CD309 Reference Antibody (olinvacimab), |
|||
| A999284 | Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab), Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab), |
|||
| A999285 | Anti-VEGFR2 / KDR / CD309 Reference Antibody (vulinacimab), Anti-VEGFR2 / KDR / CD309 Reference Antibody (vulinacimab), |
|||
| A999286 | Anti-VEGFR3 / FLT4 Reference Antibody (LY3022856), Anti-VEGFR3 / FLT4 Reference Antibody (LY3022856), |
|||
| A999287 | Anti-vWF Reference Antibody (Ajinomoto patent anti-vWF), Anti-vWF Reference Antibody (Ajinomoto patent anti-vWF), |
|||
| A999288 | Anti-vWF Reference Antibody (INSERM patent anti-vWF), Anti-vWF Reference Antibody (INSERM patent anti-vWF), |